MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    MCI reverters have a favorable cognitive prognosis and cortical integrity in Parkinson’s disease

    SJ. Chung, Y-H. Park, YH. Sohn, J-M. Lee, PH. Lee (Seoul, Republic of Korea)

    Objective: To investigate whether reversion to cognitively normal status (CogN) is clinically relevant in Parkinson’s disease with mild cognitive impairment (PD-MCI). Background: The concept of…
  • 2019 International Congress

    Cognitive profile of degenerative parkinsonian syndromes in the French West Indies and relationship with eye movements recordings

    A. Petit, A. Lackmy, R. Edragas, S. Belson, A. Mongis-Marlin, C. Stattner, F. Triboulet, G. Lepage, B. Tressieres, B. Gaymard, A. Lannuzel (Fort de France, Martinique)

    Objective: To analyze the cognitive profile of patients with degenerative parkinsonian syndromes in the French West Indies and explore the correlations between cognitive deficits and…
  • 2019 International Congress

    Parkinsonism alters directed connectivity in the cortico-subthalamo-pallidal circuit

    D. Escobar Sanabria, L. Johnson, Y. Yu, J. Zhang, S. Nebeck, Z. Busby, G. Molnar, J. Vitek (Minneapolis, MN, USA)

    Objective: To characterize how parkinsonism alters directed connectivity across the motor cortex (M1), subthalamic nucleus (STN), and internal segment of the globus pallidus (GPi). Background:…
  • 2019 International Congress

    Motor compensation in Parkinson’s disease: a multimodal neuroimaging study

    N. Villain, N. Pyatigorskaya, S. Lehericy, R. Vallabregue, S. Fernandez-Vidal, MO. Habert, G. Mangone, JC. Corvol, M. Vidailhet, D. Grabli (Paris, France)

    Objective: To study motor compensation mechanisms in Parkinson's disease. Background: Whereas akinesia in Parkinson's disease (PD) is linked to dopaminergic neurons death and striatal dopamine depletion,…
  • 2019 International Congress

    Retrospective analysis of hospitalized Parkinson ‘s disease patients from 2002 to 2014 in Suzhou district

    C. Mao, J. Chen, H. Gu, D. Chen, J. Huang, J. Chen, Y. Wang, W. Luo, C. Liu (Changshu, China)

    Objective: To analyze the reasons of admission, comorbidities, medications, and the causes of death of patients with Parkinson's disease (PD) during hospitalization in the past…
  • 2019 International Congress

    New epidemiological data of Parkinson’s Disease in Ukraine

    Y. Trufanov, N. Svyrydova, A. Galusha, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)

    Objective: To compare the prevalence of Parkinson’s Disease (PD) in Ukraine in 2010 and 2017; to compare the prevalence of PD in Ukraine with other…
  • 2019 International Congress

    Predicting active electrode selection from atlas based targets and probabilistic sweetspots in STN DBS

    T. Dembek, P. Reker, J. Petry-Schmelzer, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

    Objective: To investigate whether neuroimaging can help in choosing effective electrodes in PD patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN). Background:…
  • 2019 International Congress

    DBS in Parkinson’s disease: Experience from Egypt

    A. Mansour, Z. Fayed (Cairo, Egypt)

    Objective: To highlight our Experience in DBS for Parkinson’s in Egypt, to our knowledge we are the first team for DBS in Egypt, and so…
  • 2019 International Congress

    Transcriptome modification of anodal transcranial direct current stimulation in transgenic Parkinson’s disease mouse model

    W. Jang, H-T. Kim (Seoul, Republic of Korea)

    Objective: We tried to investigate the impact of tDCS on mRNA and microRNA expression in striatum and substantia nigra of transgenic mouse model of PD.…
  • 2019 International Congress

    The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease

    Z. Akbarkhodjaeva, DJ. Tursunov (Tashkent, Uzbekistan)

    Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley